1. Autologous and Allogeneic Transplantation for Burkitt Lymphoma Outcomes and Changes in Utilization: A Report from the Center for International Blood and Marrow Transplant Research 
Leena V. Maramattom, Parameswaran N. Hari, Linda J. Burns, Jeanette Carreras, William Arcese, Mitchell S. Cairo, Luciano J. Costa, Timothy S. Fenske, Michael Lill, Cesar O. Freytes, Robert Peter Gale, Thomas G. Gross, Gregory A. Hale, Mehdi Hamadani, Leona A. Holmberg, Jack W. Hsu, David J. Inwards, Hillard M. Lazarus, David I. Marks, David G. Maloney, Richard T. Maziarz, Silvia Montoto, David A. Rizzieri, Baldeep Wirk, James L. Gajewski 
Biology of Blood and Marrow Transplantation 
Volume 19, Issue 2, Pages (February 2013)
DOI: /j.bbmt
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidence of relapse after autologous and allogeneic transplantation for BL by disease status.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Probability of OS and PFS after autologous transplantation for BL by disease status.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Probability of OS and PFS after allogeneic transplantation for BL by disease status.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 4 Probability of OS and PFS after HCT for BL by year of HCT.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions